This is an open-label, multi-center study to evaluate the safety, tolerability, and anti-tumor activity of SNK01 in combination with AFM24 in subjects with advanced or metastatic EGFR-expressing cance
This data set consists of node and edge tables for each of the 73 years of the temporal network analysis, along with a lookup table to link author names and genders to the node/edge tables.
